K. Goss

发表

The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway.

Joanna Groden, Christopher D. Heinen, G. Babcock, 2002, Gastroenterology.

Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.

B. Aronow, D. Witte, K. Goss, 2005, Cancer research.

Regulation of Tcf7l1 DNA binding and protein stability as principal mechanisms of Wnt/β-catenin signaling.

O. Olopade, K. Goss, B. Merrill, 2013, Cell reports.

APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology

K. Goss, Jenifer R Prosperi, Matthew A. Odenwald, 2013, BMC Cancer.

Cohort profile: the ChicagO Multiethnic Prevention and Surveillance Study (COMPASS)

F. Jasmine, M. Kibriya, H. Ahsan, 2020, BMJ Open.

Signaling and Regulation EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet – Promoted Murine Colon Cancer : Role of G 1 Regulators

M. Bissonnette, A. Fichera, V. Robinson, 2011 .

EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet–Promoted Murine Colon Cancer: Role of G1 Regulators

Marc Bissonnette, Loren Joseph, John Hart, 2011, Molecular Cancer Research.

Macrophage Apoptosis by Anthrax Lethal Factor Through p 38 MAP Kinase Inhibition

G. Boivin, A. Capobianco, K. Goss, 2002 .

Janet Davison Rowley (1925–2013)

M. L. Le Beau, K. Goss, M. Beau, 2014 .

A Wnt-ow of opportunity: targeting the Wnt/beta-catenin pathway in breast cancer.

K. Goss, Jenifer R Prosperi, 2010, Current drug targets.

APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology

K. Goss, Jenifer R Prosperi, Matthew A. Odenwald, 2013, BMC Cancer.

Regulated synthesis and functions of laminin 5 in polarized madin-darby canine kidney epithelial cells.

K. Goss, K. Matlin, A. Zuk, 2006, Molecular biology of the cell.

β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells

O. Olopade, K. Goss, Jenifer R Prosperi, 2015, PloS one.

The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors

Paul Polakis, B. Fingleton, L. Matrisian, 1999, Oncogene.

Matrilysin in early stage intestinal tumorigenesis

B. Fingleton, L. Matrisian, K. Goss, 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Dysregulation of the Wnt Pathway in Solid Tumors

K. Goss, H. Luu, Jenifer R Prosperi, 2011 .

Targeting the Wnt pathway in cancer

M. Kahn, K. Goss, 2011 .

Cancer Cell Properties

Christopher D. Heinen, C. Heinen, K. Goss, 2001 .

Stem Cells , Tissue Engineering and Hematopoietic Elements Wnt /-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome

O. Olopade, M. Tretiakova, D. Huo, 2010 .

Exploiting APC function as a novel cancer therapy.

K. Goss, A. Lesko, Jenifer R Prosperi, 2014, Current drug targets.

APC (Adenomatous Polyposis Coli) Tumor Suppressor

K. Goss, J. Groden, W. Hankey, 2014 .

The APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesis.

Kenan Onel, K. Onel, K. Goss, 2015, Biochimica et biophysica acta.

A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia

T. Gilliam, Cheng Cheng, C. Pui, 2017, Cancer management and research.

Biology of the adenomatous polyposis coli tumor suppressor.

K. Goss, J. Groden, J Groden, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Strain-Specific Effects of Alachlor on Murine Olfactory Mucosal Responses

K. Goss, J. Groden, M. Genter, 2004 .

A Wnt-ow of Opportunity: Targeting the Wnt/β-Catenin Pathway in Breast Cancer

K. Goss, Jenifer R Prosperi, Jenifer R. Prosperi, 2010 .

Enhanced Tumor Formation in Mice Heterozygous for Blm Mutation

G. Boivin, A. Capobianco, K. Goss, 2002, Science.

Apc Mutation Enhances PyMT-Induced Mammary Tumorigenesis

K. Goss, A. Khramtsov, G. Khramtsova, 2011, PloS one.

Targeting loss of tumor suppressors for cancer therapeutics.

K. Goss, Jenifer R Prosperi, 2014, Current drug targets.

Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results

M. Dolan, D. Huo, S. Conzen, 2018, Breast Cancer Research and Treatment.

Hsp70 exerts oncogenic activity in the Apc mutant Min mouse model.

M. Bissonnette, Y. Tao, J. Messer, 2016, Carcinogenesis.

The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland

D. Witte, K. Goss, Jenifer R Prosperi, 2009, Journal of cellular physiology.

The Bloom's Syndrome Protein (BLM) Interacts with MLH1 but Is Not Required for DNA Mismatch Repair*

T. Kunkel, K. Bebenek, K. Goss, 2001, The Journal of Biological Chemistry.

β‐catenin regulates c‐Myc and CDKN1A expression in breast cancer cells

O. Olopade, D. Huo, K. Goss, 2016, Molecular carcinogenesis.

Wnt pathway-independent activities of the APC tumor suppressor

K. Goss, Jenifer R Prosperi, 2011 .

The Ron receptor tyrosine kinase is not required for adenoma formation in ApcMin/+ mice

K. Goss, S. Waltz, Sara E. Meyer, 2009, Molecular carcinogenesis.

Chicago EYES on Cancer: Fostering Diversity in Biomedicine through Cancer Research Training for Students and Teachers.

K. Goss, M. Dolan, Christopher G Peña, 2022, Journal of STEM outreach.